The Medicines and Healthcare products Regulatory Agency, or MHRA, of the United Kingdom announced it has approved an adapted Pfizer/BioNTech COVID-19 vaccine, or Comirnaty, that targets the KP.2 COVID-19 subvariant for adults.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFE:
- Delta reports mixed Q3, Domino’s reports earnings beat: Morning Buzz
- Morning Movers: GXO Logistics gains following report of potential sale
- Starboard Value issues letter to Pfizer board of directors
- Pfizer reports ‘positive’ results from TALAPRO-2 study of TALZENNA/XTANDI
- Pfizer’s Ex-CEO and CFO Retreat from Starboard’s Activist Campaign